Free Trial

INSPECS Group (SPEC) Competitors

INSPECS Group logo
GBX 50 -0.50 (-0.99%)
As of 03/28/2025 12:22 PM Eastern

SPEC vs. TSTL, BVC, AKR, CNSL, ODX, CTEC, AMS, INS, ARIX, and ANCR

Should you be buying INSPECS Group stock or one of its competitors? The main competitors of INSPECS Group include Tristel (TSTL), BATM Advanced Communications (BVC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), ConvaTec Group (CTEC), Advanced Medical Solutions Group (AMS), Instem (INS), Arix Bioscience (ARIX), and Animalcare Group (ANCR). These companies are all part of the "medical" sector.

INSPECS Group vs.

Tristel (LON:TSTL) and INSPECS Group (LON:SPEC) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, risk, institutional ownership, valuation, earnings, community ranking and analyst recommendations.

Tristel pays an annual dividend of GBX 13 per share and has a dividend yield of 4.3%. INSPECS Group pays an annual dividend of GBX 1 per share and has a dividend yield of 2.0%. Tristel pays out 95.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. INSPECS Group pays out -24.8% of its earnings in the form of a dividend.

Tristel has a net margin of 15.47% compared to INSPECS Group's net margin of -2.10%. Tristel's return on equity of 20.43% beat INSPECS Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Tristel15.47% 20.43% 9.89%
INSPECS Group -2.10%-4.00%0.45%

Tristel received 143 more outperform votes than INSPECS Group when rated by MarketBeat users. However, 100.00% of users gave INSPECS Group an outperform vote while only 57.36% of users gave Tristel an outperform vote.

CompanyUnderperformOutperform
TristelOutperform Votes
148
57.36%
Underperform Votes
110
42.64%
INSPECS GroupOutperform Votes
5
100.00%
Underperform Votes
No Votes

Tristel has higher earnings, but lower revenue than INSPECS Group. INSPECS Group is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tristel£42.24M3.39£6.54M£13.6621.96
INSPECS Group£195.14M0.26-£4.11M-£4.04-12.38

In the previous week, Tristel had 4 more articles in the media than INSPECS Group. MarketBeat recorded 4 mentions for Tristel and 0 mentions for INSPECS Group. Tristel's average media sentiment score of 1.10 beat INSPECS Group's score of 0.00 indicating that Tristel is being referred to more favorably in the media.

Company Overall Sentiment
Tristel Positive
INSPECS Group Neutral

50.4% of Tristel shares are owned by institutional investors. Comparatively, 67.8% of INSPECS Group shares are owned by institutional investors. 4.9% of Tristel shares are owned by company insiders. Comparatively, 25.6% of INSPECS Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Tristel has a beta of 0.23, meaning that its share price is 77% less volatile than the S&P 500. Comparatively, INSPECS Group has a beta of 2.22, meaning that its share price is 122% more volatile than the S&P 500.

Summary

Tristel beats INSPECS Group on 11 of the 17 factors compared between the two stocks.

Remove Ads
Get INSPECS Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SPEC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SPEC vs. The Competition

MetricINSPECS GroupMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£50.84M£3.55B£5.63B£2.60B
Dividend Yield2.00%1.99%4.57%4.82%
P/E Ratio-12.3819.0023.33141.07
Price / Sales0.26447.56387.54282,128.95
Price / Cash1.63146.5438.1627.97
Price / Book0.502.776.894.61
Net Income-£4.11M£99.80M£3.20B£5.79B
7 Day Performance3.61%-0.10%-2.98%1.39%
1 Month Performance8.23%119.49%1.63%7.30%
1 Year Performance5.26%112.54%9.44%112.11%

INSPECS Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SPEC
INSPECS Group
N/AGBX 50
-1.0%
N/A+5.3%£50.84M£195.14M-12.381,673Gap Down
TSTL
Tristel
N/AGBX 312.50
-3.0%
N/A-31.0%£149.28M£42.24M22.87208Insider Trade
News Coverage
BVC
BATM Advanced Communications
N/AGBX 14.28
+0.2%
N/A-19.7%£75.83M£130.32M-331.51980Analyst Forecast
Positive News
AKR
Akers Biosciences
N/AN/AN/AN/A£21.64M£2.32M-0.44120
CNSL
Cambridge Nutritional Sciences
N/AGBX 2.88
-5.6%
N/AN/A£6.85M£9.77M-362.103,200Gap Down
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55M-220.0091Gap Down
CTEC
ConvaTec Group
N/AGBX 260.40
+1.5%
GBX 301.67
+15.8%
-9.9%£6.62B£2.71B43.8510,000High Trading Volume
AMS
Advanced Medical Solutions Group
2.2275 of 5 stars
GBX 202
+2.9%
GBX 300
+48.5%
+20.9%£436.17M£132.18M39.1410News Coverage
High Trading Volume
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500
ARIX
Arix Bioscience
N/AN/AN/AN/A£183.73M£14.16M1,290.919
ANCR
Animalcare Group
N/AGBX 218.50
-0.2%
N/A+4.1%£149.81M£84.90M4.07220
Remove Ads

Related Companies and Tools


This page (LON:SPEC) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners